Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Adragos Pharma Takes Over Clinigen's Development Unit, Lamda Laboratories | Contract Pharma
Breaking News

Adragos Pharma Takes Over Clinigen’s Development Unit, Lamda Laboratories

Acquisition strengthens Adragos' end-to-end integrated pharmaceutical product development service offering.

Adragos Pharma GmbH, a contract development and manufacturing organization (CDMO), acquired Lamda Laboratories S.A. in Athens.

With the transaction, Adragos Pharma will operate three sites in Europe and five globally. The acquisition of Lamda Laboratories significantly expands Adragos’ pharmaceutical product development, regulatory affairs, and supply chain management services for its global pharmaceutical customers.

Lamda will continue to provide services for Clinigen.

The Athens site is equipped with state-of-the-art equipment, which also allows the handling of highly potent pharmaceuticals, as well as established quality systems and a proven track record of delivering complex developments to customers on time. The official handover of the facility took place on April 3.

Andreas Raabe, CEO of Adragos Pharma said: “We are pleased to have carried out this acquisition. Lamda is of great importance to us because it extends our value chain coverage from pure manufacturing to development, allowing us to address a new customer group. At the same time, we can offer existing Lamda customers production capacity within the Adragos Group and existing Adragos Manufacturing customers a broader service offering.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters